Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Anthony Central Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Porter Adventist Hospital
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Porter Adventist Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Presbyterian - St. Luke's Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Joseph Hospital
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Rose Medical Center
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Rose Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Colorado Cancer Research Program, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Swedish Medical Center
mi
from
Englewood, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Swedish Medical Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
North Colorado Medical Center
mi
from
Greeley, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
North Colorado Medical Center
mi
from
Greeley, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Sky Ridge Medical Center
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Hope Cancer Care Center at Longmont United Hospital
mi
from
Longmont, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
McKee Medical Center
mi
from
Loveland, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Mary - Corwin Regional Medical Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
North Suburban Medical Center
mi
from
Thornton, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
North Suburban Medical Center
mi
from
Thornton, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Exempla Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Graham Hospital
mi
from
Canton, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Carthage
mi
from
Carthage, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Memorial Hospital
mi
from
Carthage, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Eureka Community Hospital
mi
from
Eureka, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Galesburg
mi
from
Galesburg, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Galesburg
mi
from
Galesburg, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Havana
mi
from
Havana, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Havana
mi
from
Havana, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Mason District Hospital
mi
from
Havana, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Mason District Hospital
mi
from
Havana, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Kewanee Clinic
mi
from
Kewanee, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
McDonough District Hospital
mi
from
Macomb, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
McDonough District Hospital
mi
from
Macomb, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
mi
from
Moline, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
mi
from
Moline, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Clinical Research Facility
mi
from
Moline, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Clinical Research Facility
mi
from
Moline, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Monmouth
mi
from
Monmouth, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Monmouth
mi
from
Monmouth, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
BroMenn Regional Medical Center
mi
from
Normal, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Community Cancer Center
mi
from
Normal, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Community Cancer Center
mi
from
Normal, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Community Cancer Center
mi
from
Normal, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
OSF Saint Elizabeth Medical Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Oncology Hematology Associates of Central Illinois, PC - Ottawa
mi
from
Ottawa, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Cancer Treatment Center at Pekin Hospital
mi
from
Pekin, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Proctor Hospital
mi
from
Peoria, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Proctor Hospital
mi
from
Peoria, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Oncology Hematology Associates of Central Illinois, PC - Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated:  11/23/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed CINV (Chemotherapy Induced Nausea and Vomiting) in Patients Receiving Highly Emetogenic Chemotherapy
Status: Enrolling
Updated: 11/23/2015
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials